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In Vitro Induction of Cartilage-specific Macromolecules
by a Bone Extract
Subcutaneous implantation ofdemineralized bone matrix has
been shown to evoke the induction of responding mesenchy-
mal cells into chondroblasts (cartilage-specific cells), an early
step in endochrondral bone formation (1-3). It has also been
shown that the inducing factor(s) is extractable in stable form
with 4 M guanidine - HCI from acid demineralized bone pow-
eder (4, 5). Freshly excised skeletal muscle cells from embry-
onic or neonatal rats cultured on demineralized bone also
respond to a cartilage-induction factor (6-8). In monolayer
culture, however, chondrogenic development is inhibited by
binding ofthe cells to the plastic culture dish (9, 10). Indeed,
the interaction of the cells with a plastic surface appears to
promote the dedifferentiation of chondrogenic cells into cells
with a fibroblastic morphology that no longer synthesize
cartilage proteoglycan and type II collagen (11). However,
Anastassiades et al. (9) showed that a 4-M guanidine- HCI
extracted, saline-soluble fraction prepared from bone matrix
increases glycosaminoglycan secretion by cultured fibroblasts.
We have expanded on these observations and developed a
rapid, sensitive in vitro system for induction of cartilage
synthesis in response to solubilized bovine bone chondrogenic
factor(s). Specificity and quantitation was obtained by em-
ploying antibodies to rat cartilage proteoglycan and rat type
II collagen.
MATERIALS AND METHODS
Tissue Preparation and Extraction:
￿
Fresh metatarsal bovine bone
were frozen overnight at -70°C. Frozen bone was cleaned of periosteum,
broken into fragments, and pulverized in liquid nitrogen. Pulverized bone was
washed overnight in 0.01 N HCI at 4°C and defatted with ethanol and etheras
described elsewhere (3). Bone powder was demineralized with 50 vol (wt/vol)
of 0.5 N HCI at 4°C for 16 h. Acid was removed and pellet was washed with
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￿
An in vitro system has been developed to study the onset of chondrogenesis. Embryonic
rat muscle mesenchymal cells, when treated in suspension culture with an extract of bovine bone
matrix, synthesized cartilage-specific proteoglycan and type II Collagen . The synthesis of these two
macromolecules was assayed by the enzyme-linked immunosorbent assay inhibition technique.
Further evidence of chondrogenesis was demonstrated by morphological changes of treated cells
when cultured in firm agarose and stained for metachromatic matrix. Even with crude bone matrix
extracts, the assay was sensitive at the microgram level and significant differences in cartilage
macromolecules compared with controls were observed in 2-3 d . In vivo the same extract induced
first cartilage and then bone.
distilled water to pH 4. Demineralized bone was extracted with 10 vol (vol/
vol) of 4 M guanidine-HCI, 10 mM EDTA, 1 mM phenylmethylsulfonyl
fluoride, and 10 mM N-ethylmaleimide, pH 6.5 for 16 h at 4°C. The suspension
was centrifuged at 10,000 rpm for 30 min. The pellet was washed with another
5 vol ofthe4-Mguanidine -HCI solutionandcentrifugedasabove. Supernatants
were combined, dialyzed extensively against water, and lyophilized.
Ion Exchange Fractionation:
￿
An anionic exchanger, DEAE-cellu-
lose (WhatmanDE-52; Whatman Chemicals, Kent, England),equilibrated with
6 M urea, 1 mM phenylmethylsulfonyl fluoride, t mM N-ethylmaleimide, 20
mM phosphate (made from stock solution of 0.15 M Na2HP0,, 0.15 M
NaH2PO4) and 50 mM NaCl adjusted to pH 7.2 with appropriate 0.15 M
phosphate solution. The lyophilizedguanidine -HCI extractdissolved in DEAE-
cellulose equilibration buffer was mixed with DEAEcellulose (20 mg of dry
extract per gram of DEAF) that had been equilibrated with the same buffer
and stirred gently overa period of I-2 h at room temperature. The nonbound
fraction, which constituted ^-50% (dry weight) of the material applied to the
column, was recovered by filtration. The bound fraction was eluted by increas-
ing the NaCl concentration to I M in starting buffer. For in vivo studies,
nonbound and bound fractionswere dialyzedextensivelyagainst distilled water,
lyophilized, rehydrated with 1 vol of distilled water, and dehydrated with
ethanol followed by ether to make a coarse powder. For in vitro assays, these
fractions were solubilized in 6 M urea sterilized by filtration (0.2-pm Millipore
filter; Millipore Corp., Bedford, MA) and dialyzed extensively against sterile
water followed by sterile PBS.
Isolation of Cells:
￿
Embryonic rat muscle cells were obtained from the
cellular outgrowth of minced muscle tissue dissected from the upper limbs of
19-d-old Sprague-Dawley rat fetuses. Tissue and cells were cultured in Mini-
mum Essential Medium with 10% fetal calf serum, 50 U penicillin, and 50,ug
streptomycin per ml. At confluence, cells were trypsinized and diluted 1 :2 for
replating. Cells were used forexperimentswithin the first three passages. Except
where noted, culture solutions and sera were obtained from GIBCO Labora-
tories, Grand Island, NY.
Cell Culture:
￿
Cells were grown in monolayer or in suspension culture.
Suspension cultures were established by growing the cells on bacteriological
plates, poly-D-lysine (Sigma Chemical Co., St. Louis, MO) treated plates (see
below) or on agarose (Bio-Rad Laboratories, Richmond, CA; #162-0100).
Tissue culture plates (35 mm. Costar, Cambridge, MA) were treated with poly-
D-lysine by coating with l ml ofa 1 mg/ml aqueous solution. The plates were
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treated in this manner were shown to prevent significant cell attachment in a
manner resembling bacteriological plates. For assay, cells were seeded at 5 x
105 cells per 35-mm well in Hams F-12 medium containing 10% fetal calf
serum and a weighed portion of the dry bone extract. Parallel cultures were
also established which included 50 ag/ml 0-aminoproprionitrile as a collagen
cross-linking inhibitor (l2) . Viable cells were counted in a hemocytometer
using trypan blue .
Preparation of Agarose Gel Cultures :
￿
Cells were embedded in
agarose gels according to the method of Benya and Shaffer (11) . Briefly, 0.15
ml of 1% agarose (Bio-Rad Laboratories, #162-0100) heated above 90°C was
added to each 17-mm well (Falcon Labware, Oxnard, CA) and allowed to gel
on a level surface at room temperature . Low gel melting agarose (Bio-Rad
Laboratories, #162-0017), 2% at 38°C, was mixed with an equal volume of
two times concentrated Ham's F-12 and held at 38°C . The agarose/F-12
solution was then mixed with an equal volume of cell suspension and 0.15 ml
was added to each well. When firm, gels were overlaid with 1 .0 ml ofmedia,
cultured at 37°C in 5% C02, and fed twice weekly . Media for cell feeding
consisted of Ham's F-12 with 10% heat-inactivated fetal calf serum, and
antibiotics. Agarose solutions were sterilized by autoclaving at 121°C for 15
min prior to use .
Staining of Agarose Gel Cultures for Metachromasia :
￿
After
14d ofculture, gels werefixed and stained withToluidine blue(Sigma Chemical
Co.) as described by Horwitz and Dorfman (13) . Gels were briefly rinsed twice
in PBS, fixed in 40% formalin, rinsed twice with distilled water, stained with
0.5% Toluidine blue in 25% acetone, and washed with distilled water.
Antisera :
￿
Antisera torat cartilageproteoglycan and type II collagenwere
raised in rabbits. Both antigens wereextracted from Swarm rat chondrosarcoma
tissue (14) . Type Il collagen was isolated from a 1 M NaCI extract of sarcoma
tissue followed by precipitation with 0.02M sodium phosphate (l6). Proteogly-
canswere eluted from a DEAE-cellulose column with 2M NaCl (16), followed
by gel filtration on Sephadex G-200 (15) . Elution was monitored by uronic
acid (25). Antigens were dissolved in PBS at I mg/ml and were mixed with an
equal volume of complete Freund's adjuvant prior to subcutaneous injection.
Four weeks later animals were boosted with 1 mg antigen in incomplete
adjuvant. Boosters were given two more times at 2-wk intervals . Significant
titerswere obtained from seracollectedfollowing the third and fourthinjections.
Antiserum to type II collagen was affinity purified (17), employing highly
purified type II collagen from the chondrosarcoma carried in lathyritic rats (14)
and shown not to cross-react with type I collagen . In the experiments reported
here antiserum to proteoglycan was not affinity purified. However, in selected
experiments using affinity purified antibodies identical results were obtained .
Cross reactivity of cartilage proteoglycan antiserum with bone proteoglycan,
hyaluronic acid, and the bone extract was found to be negligible . Treatment of
proteoglycan with chondroitinase ABC had little effect on antigenicity; this
suggests that the antiserum is directed primarily against core protein or oligo-
saccharides attached to core protein .
Enzyme-linked Immunosorbent Assay:
￿
Synthesis of proteogly-
can and type 11collagen was measured directly in culture media. Media samples
were collected at the indicated times and stored at -70°C. Enzyme-linked
immunosorbent assay was performed essentially as described by Rennard et al .
(18) using polystyrene microplates (Flow Laboratories, Inc., McLean, VA) .
Horseradishperoxidaseconjugated goatanti-rabbit IgG (Tago Inc., Burlingame,
CA) was used as the second antibody. Samples were either assayed directly or
diluted in PBS, 0.05% Tween 20, 1 mg/ml BSA and quantitated by use of an
inhibition enzyme-linked immunosorbent assay (19) using chondrosarcoma
proteoglycan or type II collagen as a standard.
RESULTS
In vivo experiments with 4M guanidine -HCl soluble material
extracted from rat demineralized bone and fractionated on
DEAE-cellulose have shown that only the nonbound material
induces cartilage and bone formation when implanted in rats
(5). Similarly, we found the equivalent fraction from bovine
demineralized bone to be a potent inducer of chondrogenesis
and osteogenesis when implanted subcutaneously in rats .
Activity was not detected in material bound to DEAE-cellu-
lose (data not shown) .
In the present study, rat muscle mesenchymal cells grown
in suspension culture and treated with the DEAE-cellulose
nonbound fraction of bone extract underwent dramatic bio-
chemical changes . As shown in Fig . 1, cells grown in suspen-
sion on bacteriological plates, poly-D-lysine coated plates, or
0
(7
a
z
12 .0
10.0
8.0
4.0
2.0
0
a
￿
b
￿
c
￿
d
FIGURE 1
￿
Synthesis of cartilage proteoglycan (PG) by cells cultured
in a, monolayer ; b, poly-D-lysine coated plates ; c, bacteriological
plates ; d, agarose coated plates. Cells were seeded at 5 x 105 cells
per well in the presence (solid bars) or absence (open bars) of 20
g/ml of DEAE-cellulose nonbound extract. Media were collected
after 7 d in culture and tested for cartilage proteoglycan enzyme-
linked immunosorbent assay .
on agarose responded best to the DEAE-cellulose nonbound
extract . Cells in suspension in the presence of extract synthe-
sized 8-10 times as much proteoglycan as cells in suspension
in the absence of extract, and 3-4 times as much as cells in
monolayer in the presence of extract. Response to the active
extract was dose dependent ; synthesis oftype II collagen and
proteoglycan was detected with 5 ug/ml and continued to
increase up to 50,ug/ml of DEAE-cellulose nonbound mate-
rial in the culture media.
There was a significant increase in cartilage proteoglycan
synthesis (Fig. 2A) as well as type II collagen synthesis (Fig .
2B) when cells were cultured with 20 Pg/ml DEAE-cellulose
nonbound material on poly-D-lysine coated culture plates . In
both cases, increases in the amount of the cartilage markers
could be clearly seen as early as 2 d after treatment with a
further increase at 3 d . The collagen cross-linking inhibitor a-
APN has been used extensively in cell culture systems to
increase the proportion of matrix molecules released into the
culture medium (20, 21) . Thiscompound was effective in our
experiments in increasingthe amounts ofboth type II collagen
and proteoglycan in the medium . Although not quantitated,
these macromolecules were detected in both the cell layer and
the matrix by immunofluorescence. Control experiments with
rat chondrocyte cultures gave similar results showing the
specificity of the test system .
Agarose gel culture has been shown to be permissive to the
chondrocyte phenotype as evidenced by type II collagen and
cartilage proteoglycan synthesis (11) . To confirm morpholog-
ically the chondrogenic phenotype of cells treated with the
DEAE-cellulose nonbound fraction in suspension, they were
embedded in agarose gels . After 14 d in agarose gels, cells
treated with active extract for the first 7 d showed large
colonies ; and substantial numbers ofthese cells had the grainy
refractile appearance typical of chondroblasts (Fig . 3A) . Cells
treated with the DEAE-cellulose bound fraction, on the other
hand, contained many degenerated cells and few large colo-
nies (Fig. 3 B) . When stained with Toluidine blue (not shown),
metachromatic halos, indicative of a proteoglycan matrix,
appeared around a majority of cells treated with the DEAE-
cellulose nonbound fraction . Cells treated with the DEAE-
cellulose bound fraction or untreated, showed no metachro-
masia. Immunobiochemical analysis of macromolecules ex-
tracted from these gels revealed the synthesis of cartilage
proteoglycan and type II collagen in the presence of active
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FIGURE 2 Synthesis of cartilage biochemical markers by mesen-
chymal cells cultured with DEAE-cellulose nonbound extract . Cells
were cultured on poly-D-lysine coated plates in Hams F-12 medium,
10% FCS, in the presence (circles) or absence (squares) of 20 g/ml
dry extract . Parallel cultures were incubated in the presence of 50
g/ml ß-aminoproprionitrile (open symbols) . Media were collected
at the indicated times and assayed for proteoglycan (PG) synthesis
(A) or type II collagen synthesis (B) . Values are normalized for cell
number.
extractin the samemanner as shown for cells grown on poly-
D-lysine coated plates (Fig . 2) .
The increases in cartilage proteoglycan and type II collagen
synthesis observed in vitro in our studies resemble those
observed in vivo after implantation of demineralized bone
matrix (22) . In both instances, increases in cartilage proteo-
glycan synthesis can be detected as early as 2-3 d after
exposure to active material . The in vitro system is of course
simpler, more sensitive, and easily quantitated.
Although it is well known that bone extracts contain mi-
togenic factors (23, 24), the finding that significant increases
in type II collagen and proteoglycan synthesis occurred as
soon as 2 d after treatment argues against cell division being
an important factor. In confirmation, no significant differ-
ences in viable cell numbers were seen in cultures treated with
DEAE-cellulose nonbound or bound fractions, or in control
FIGURE 3
￿
(A) Cells treated with DEAE-cellulose nonbound fraction
in suspension (poly-D-lysine coated plate) for 7 d and embedded
in agarose for 14 d . Cells are large, form clusters, and have the
grainy appearance of actively synthesizing cells . (B) As in A but
treated with DEAE-cellulose bound fraction . Cells form some clus-
ters but do not increase in size . Control (untreated) cells appeared
identical to these . x 200.
cultures after 3 d on poly-D-lysine coated or bacteriological
plates . Similarly, cells treated with active extract showed no
increase in DNA synthesis over controls as demonstrated by
[ 3H]thymidine incorporation studies (in preparation) .
Although the mechanism of action of the bone extract is
not known, the significant changes in cell morphology and
biochemical markers suggest that as yet unidentified muscle-
derived mesenchymal cells undergo a true change in pheno-
type . The development ofa rapid and sensitive in vitro system
should be an important tool in the purification and charac-
terization of chondroblast inducing factor(s), and might be an
avenue to study the mechanism of endochondral bone for-
mation as induced by demineralized bone matrix factor(s).
We are indebted to Dr . R . Armstrong and S . Chu for the histology,
toT. Thomas andM. R . Ranganathan for preparation ofthe DEAE-
cellulose fractions, to Dr. R. Siegel and J . Fu for preparation of
antibodies, and to Drs. J . McPherson and B . Pharriss fortheir support
and critical suggestions .
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